What is WAL's health score?

WESTERN ALLIANCE BANCORPORATION (WAL) has a TradeApes health score of 45 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is WAL's estimated fair value?

Based on our 5-year discounted cash flow model, WESTERN ALLIANCE BANCORPORATION's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is WAL undervalued or overvalued?

Our model currently rates WAL as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

1 free score card remaining

WESTERN ALLIANCE BANCORPORATION (WAL)

Financials Undervalued medium mixed

$82.3

Updated: 2026-07-18

TradeApes Score

Financial Strength

35 Weak

Operating Trend

50 Mixed

Relative Value

50 Mixed

Capital Allocation

20 Stressed

Risk Management

80 Strong

Key Findings

+ Low P/E — below 12×, potential value relative to earnings

Unlock Full Report →

− Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees

Unlock Full Report →

Industry Related Stocks

Ameris Bancorp (ABCB) ACNB CORP (ACNB) DEUTSCHE BANK AKTIENGESELLSCHAFT (ADZCF) Ally Financial Inc. (ALLY) ALERUS FINANCIAL CORP (ALRS) Amalgamated Financial Corp. (AMAL)

See all Financials stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.